Home NDC 68001-666 Aprepitant
Product NDC 68001-666
11-digit product format 680010666
Labeler code 68001
Product ID 68001-666_5f1116f1-3149-848f-e063-6294a90acdc6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Aprepitant
Dosage form CAPSULE
Route ORAL
Labeler BluePoint Laboratories
Application ANDA207777
Marketing category ANDA
Marketing start 2026-01-29
Substance APREPITANT
Active strength 40 mg/1
Pharmacologic classes Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A207777-001 APREPITANT APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 A207777-002 APREPITANT APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 A207777-003 APREPITANT APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 132 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 c2088c7a36db…2026-09-14 22:38:34 2026-08 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 84e616aacf4f…2026-08-18 06:07:40 2026-07 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A207777-002 APREPITANT 80MG CAPSULE / ORAL AB 2017-10-12 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A207777-003 APREPITANT 125MG CAPSULE / ORAL AB 2017-10-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A207777-001 APREPITANT 40MG CAPSULE / ORAL AB 2017-10-12 79d66fd596c7…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 132 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Aprepitant
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength APREPITANT 40 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68001-666-01 Aprepitant 1 in 1 BLISTER PACK CAPSULE 1 2 68001-666-01 Aprepitant 1 in 1 CARTON CAPSULE 1 2 68001-666-17 Aprepitant 5 in 1 CARTON CAPSULE 5 2 68001-666-17 Aprepitant 1 in 1 BLISTER PACK CAPSULE 1 2
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 68001-666-01 68001066601 1 BLISTER PACK in 1 CARTON (68001-666-01) / 1 CAPSULE in 1 BLISTER PACK 1 blister pack 2026-01-29 No No Current 68001-666-17 68001066617 5 BLISTER PACK in 1 CARTON (68001-666-17) / 1 CAPSULE in 1 BLISTER PACK 5 blister pack 2026-02-02 No No Current